Prostaglandins of the e series inhibit monoamine release via EP3 receptors: Proof with the competitive EP3 receptor antagonist L-826,266

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 381, Issue 1, 2010, Pages 21-31

  Gunther J ^a   Schulte, K ^a   Wenzel, D ^a   Malinowska, B ^b   Schlicker, E ^a  

^a UNIVERSITY OF BONN   (Germany)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

35S GTP S binding; L 826,266; Noradrenaline release; Presynaptic EP3 receptor; Serotonin release; Virodhamine

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 5 BROMO N [3 (5 CHLORO 2 NAPHTHALEN 2 YLMETHYLPHENYL)ACRYLOYL] 2 METHOXYBENZENESULFONAMIDE; ACETYLCHOLINE; BENZENESULFONAMIDE DERIVATIVE; CHOLINE; DESIPRAMINE; DOPAMINE; FEMOXETINE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HEMICHOLINIUM 3; L 826266; MONOAMINE; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; NAPROXEN; NORADRENALIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; RAUWOLSCINE; SEROTONIN; SULPROSTONE; TRITIUM; UNCLASSIFIED DRUG; VIRODHAMINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; FEMALE; MALE; MOUSE; NONHUMAN; NORADRENALIN RELEASE; RAT; RETINA NERVE CELL; SEROTONIN RELEASE; VAS DEFERENS;

ACRYLAMIDES; ANIMALS; BIOGENIC MONOAMINES; FEMALE; GUINEA PIGS; MALE; MICE; MICE, INBRED C57BL; NAPHTHALENES; PROSTAGLANDINS E; RATS; RATS, WISTAR; RECEPTORS, PROSTAGLANDIN E; TISSUE DISTRIBUTION;

EID: 74349105894     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-009-0478-9     Document Type: Article

References (41)

1. SPH Alexander A Mathie JA Peters 2008 Guide to receptors and channels (GRAC), 3rd edition (2008 revision) Brit J Pharmacol 153 Suppl 2 S1 S209 10.1038/sj.bjp.0707746
2. 2 on central and peripheral catecholamine neurons Eur J Pharmacol 21 362 368 10.1016/0014-2999(73)90139-8 4145320
3. S Boehm H Kubista 2002 Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors Pharmacol Rev 54 43 99 10.1124/pr.54.1.43 1:CAS:528:DC%2BD38XislOgtb4%3D 11870260 (Pubitemid 34208829)
4. CS Breivogel MJ Walker SM Huang MB Roy SR Childers 2004 Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids Neuropharmacology 47 81 91 10.1016/j.neuropharm.2004.02.017 1:CAS:528:DC%2BD2cXksVagtbw%3D 15165836 (Pubitemid 38686313)
5. P Clark SE Rowland D Denis MC Mathieu R Stocco H Poirier J Burch Y Han L Audoly AG Therien D Xu 2008 MF498 [N-[[4-(5, 9-diethoxy-6-oxo-6, 8-dihydro-7H-pyrrolo[3, 4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl]-2-(2- methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis J Pharmacol Exp Ther 325 425 434 10.1124/jpet.107.134510 1:CAS:528:DC%2BD1cXlsVOjsbw%3D 18287210 (Pubitemid 351574801)
6. Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P (1990) Prostanoids and their receptors. In: Emmett JC (ed) Comprehensive medicinal chemistry. The rational design, mechanistic study and therapeutic application of chemical compounds, vol 3. Membranes and receptors. Pergamon, Oxford, pp 643-714
7. BF Cravatt K Demarest MP Patricelli MH Bracey DK Giang BR Martin AH Lichtman 2001 Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc Natl Acad Sci 98 9371 9376 10.1073/pnas.161191698 1:CAS:528:DC%2BD3MXlvFSrsbo%3D 11470906 (Pubitemid 32743923)
8. Di Marzo V, De Petrocellis L, Bisogno T (2005) The biosynthesis, fate and pharmacological properties of endocannabinoids. In: Pertwee RG (ed) Handbook of experimental pharmacology, vol 168. Springer, Berlin, pp 147-185
9. 2 on noradrenaline release in the mouse brain cortex Naunyn Schmiedebergs Arch Pharmacol 351 46 52 10.1007/BF00169063 1:CAS:528:DyaK2MXktVGltrg%3D 7715741
10. H Fuder E Muscholl 1995 Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves Rev Physiol Biochem Pharmacol 126 265 412 10.1007/BFb0049778 1:CAS:528:DyaK2MXktlSmsL0%3D 7886380
11. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbook of experimental pharmacology, vol 33. Springer, Berlin, pp 283-335
12. J Grainger G Boachie-Ansah 2001 Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels Brit J Pharmacol 134 1003 1012 10.1038/sj.bjp.0704340 1:CAS:528:DC%2BD3MXosVGrsLw%3D
13. HG Güllner 1983 The interactions of prostaglandins with the sympathetic nervous system-a review J Auton Nerv Syst 8 1 12 10.1016/0165-1838(83)90017-6 6308093
14. 1 on acetylcholine release from the cat brain Acta Physiol Acad Sci Hung 54 177 185 1:CAS:528:DyaL3cXhvFWmtbc%3D 543406
15. N Hatae Y Sugimoto A Ichikawa 2002 Prostaglandin receptors: advances in the study of EP3 receptor signaling J Biochem 131 781 784 1:CAS:528: DC%2BD38XlslKktL0%3D 12038972
16. 3 receptor antagonists L-798106 and L-826266 on guinea-pig aorta Fundam Clin Pharmacol 22 Suppl 2 73
17. RL Jones MA Giembycz DF Woodward 2009 Prostanoid receptor antagonists: development strategies and therapeutic applications Brit J Pharmacol 158 104 145 10.1111/j.1476-5381.2009.00317.x 1:CAS:528:DC%2BD1MXhsVKmu7bJ
18. 3 prostanoid receptor Bioorg Med Chem 9 1977 1984 10.1016/S0968-0896(01)00110-9 1:CAS:528:DC%2BD3MXlvFWiur4%3D 11504634 (Pubitemid 32739185)
19. CA Kassuya J Ferreira RF Claudino JB Calixto 2007 Intraplantar PGE2 causes nociceptive behaviour and mechanical allodynia: the role of prostanoid E receptors and protein kinases Brit J Pharmacol 150 727 737 10.1038/sj.bjp. 0707149 1:CAS:528:DC%2BD2sXjtFCqtL0%3D (Pubitemid 46440219)
20. Kenakin T (1993) Pharmacological analysis of drug-receptor interaction, 2nd edn. Raven, New York
21. H Kozłowska M Baranowska E Schlicker M Kozłowski J Laudański B Malinowska 2008 Virodhamine relaxes the human pulmonary artery via the endothelial cannabinoid receptor and indirectly via a cyclooxygenase product Brit J Pharmacol 155 1034 1042 10.1038/bjp.2008.371
22. R Langenbach SG Morham HF Tiano CD Loftin BI Ghanayem PC Chulada JF Mahler CA Lee EH Goulding KD Kluckman HS Kim O Smithies 1995 Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 483 492 10.1016/0092-8674(95)90126-4 1:CAS:528:DyaK2MXpt1Olt78%3D 8521478
23. SG Morham R Langenbach CD Loftin HF Tiano N Vouloumanos JC Jennette JF Mahler KD Kluckman A Ledford CA Lee O Smithies 1995 Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 83 473 482 10.1016/0092-8674(95)90125-6 1:CAS:528:DyaK2MXpt1Olt74%3D 8521477
24. R Naeije S Huez 2007 Expert opinion on available options treating pulmonary artery hypertension Expert Opin Pharmacother 8 2247 2265 10.1517/14656566.8.14.2247 1:CAS:528:DC%2BD2sXhtFeqtrnE 17927481 (Pubitemid 350001588)
25. P Oliva L Berrino V de Novellis E Palazzo I Marabese D Siniscalco M Scafuro L Mariani F Rossi S Maione 2006 Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia Eur J Pharmacol 530 40 47 10.1016/j.ejphar.2005.11.025 1:CAS:528:DC%2BD28XhsFertQ%3D%3D 16360148 (Pubitemid 43037122)
26. 2 receptors Neuroscience 152 1110 1118 10.1016/j.neuroscience.2008. 01.005 1:CAS:528:DC%2BD1cXksVamtbY%3D 18329178
27. MS Oliveira AF Furian LM Rambo LR Ribeiro LF Royes J Ferreira JB Calixto LF Otalora ER Garrido-Sanabria CF Mello 2009 Prostaglandin E2 modulates Na+, K+-ATPase activity in rat hippocampus: implications for neurological diseases J Neurochem 109 416 426 10.1111/j.1471-4159.2009.05961.x 1:CAS:528: DC%2BD1MXksVKgurs%3D 19200345
28. Pertwee RG (2005) Pharmacological actions of cannabinoids. In: Pertwee RG (ed) Handbook of experimental pharmacology, vol 168. Springer, Berlin, pp 1-51
29. AC Porter JM Sauer MD Knierman GW Becker MJ Berna J Bao GG Nomikos P Carter FP Bymaster AB Leese CC Felder 2002 Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J Pharmacol Exp Ther 301 1020 1024 10.1124/jpet.301.3.1020 1:CAS:528: DC%2BD38XktlGjsLc%3D 12023533 (Pubitemid 34595094)
30. W Reimann HB Steinhauer L Hedler K Starke G Hertting 1981 Effect of prostaglandins D2, E2 and F2α on catecholamine release from slices of rat and rabbit brain Eur J Pharmacol 69 421 427 10.1016/0014-2999(81)90445-3 1:CAS:528:DyaL3MXhtlart7c%3D 7250181 (Pubitemid 11137147)
31. V Schlemper R Medeiros J Ferreira MM Campos JB Calixto 2005 Mechanisms underlying the relaxation response induced by bradykinin in the epithelium-intact guinea-pig trachea in vitro Brit J Pharmacol 145 740 750 10.1038/sj.bjp.0706222 1:CAS:528:DC%2BD2MXmt1Wmsrw%3D (Pubitemid 41076280)
32. 2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones Brain Res Bull 47 129 132 10.1016/S0361-9230(98)00068-9 1:CAS:528:DyaK1cXnt12ru7w%3D 9820729 (Pubitemid 28502853)
33. 2 Naunyn Schmiedebergs Arch Pharmacol 335 646 651 10.1007/BF00166981 1:CAS:528:DyaL2sXkslWnt7c%3D 3476858 (Pubitemid 17112948)
34. E Schlicker J Timm M Göthert 1996 Cannabinoid receptor-mediated inhibition of dopamine release in the retina Naunyn Schmiedebergs Arch Pharmacol 354 791 795 10.1007/BF00166907 1:CAS:528:DyaK2sXktFensw%3D%3D 8971741
35. K Starke 1977 Regulation of noradrenaline release by presynaptic receptor systems Rev Physiol Biochem Pharmacol 77 1 124 10.1007/BFb0050157 1:STN:280:DyaE2s7is12mtA%3D%3D 14389
36. K Starke M Göthert H Kilbinger 1989 Modulation of neurotransmitter release by presynaptic autoreceptors Physiol Rev 69 864 989 1:CAS:528: DyaL1MXlt1Oisr8%3D 2568648
37. RT van Dross 2009 Metabolism of anandamide by COX-2 is necessary for endocannabinoid-induced cell death in tumorigenic keratinocytes Mol Carcinog 48 724 732 10.1002/mc.20515 19148897
38. 2 Res Commun Chem Pathol Pharmacol 14 431 436
39. q-protein- coupled receptors Fundam Clin Pharmacol 15 393 400 10.1046/j.1472-8206.2001. 00056.x 1:CAS:528:DC%2BD38Xht1Kqt74%3D 11860527 (Pubitemid 34227106)
40. 2 receptor 3 Proc Natl Acad Sci 104 11712 11717 10.1073/pnas.0701700104 1:CAS:528: DC%2BD2sXotVaksb0%3D 17606905 (Pubitemid 47175078)
41. Wieland T, Jakobs KH (1994) Measurement of receptor-stimulated guanosine 5′-O-(γ-thio)triphosphate binding by G proteins. In: Iyengar R (ed) Methods in enzymology, vol 237. Academic, London, pp 3-13